Daniel Abdun-Nabi - Jun 1, 2023 Form 4 Insider Report for Aptevo Therapeutics Inc. (APVO)

Role
Director
Signature
/s/ SoYoung Kwon, Attorney-in-Fact
Stock symbol
APVO
Transactions as of
Jun 1, 2023
Transactions value $
$0
Form type
4
Date filed
6/2/2023, 04:43 PM
Previous filing
Aug 10, 2022
Next filing
Aug 10, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction APVO Common Stock Options Exercise +297 +6.64% 4.77K Jun 1, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction APVO Restricted Stock Unit Options Exercise $0 -297 -49.92% $0.00 298 Jun 1, 2023 Common Stock 297 Direct F1, F2
transaction APVO Restricted Stock Unit Award $0 +3.57K $0.00 3.57K Jun 2, 2023 Common Stock 3.57K Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted Stock Units ("RSUs") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis.
F2 On June 1, 2021, the reporting person was granted 893 RSUs, vesting in three approximately equal annual installments beginning on June 1, 2022.
F3 The RSUs vest in full on the first anniversary of the date of grant.